Company / Current Liabilities
PRECISION BIOSCIENCES INC Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$8.9M
FY2025
5-year range
$8.9M / $59.7M
FY2021-FY2025
Trend
-40.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has declined for 3 consecutive years, from $60M in FY2022 to $9M in FY2025.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of -26.9%.
Improved from $50M to $9M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -46.9%
- 5-Year CAGR
- -26.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- PRECISION BIOSCIENCES INC's current liabilities has declined for 3 consecutive years.
- 5-year CAGR of -26.9%, indicating a declining trend.
- In FY2025, current liabilities decreased 40.5% year-over-year.
- Peak current liabilities was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.9M | -40.5% |
| FY2024 | $15.0M | -70.0% |
| FY2023 | $50.0M | -16.2% |
| FY2022 | $59.7M | +65.8% |
| FY2021 | $36.0M | -16.0% |
| FY2020 | $42.8M | +59.0% |
| FY2019 | $26.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026